Sickle cell disease (SCD), which affects approximately 100,000 individuals in the USA and
more than 3 million worldwide, is caused by mutations in the βb globin gene that result in …

Abstract New York City has emerged as one of the epicenters of the SARS‐COV‐2
pandemic, with the Bronx being disproportionately affected. This novel coronavirus has …

Previous studies have shown that patients with sickle cell disease (SCD) are at high risk for
obstructive sleep apnea (OSA). In the current study, we aimed to systematically review the …

Abstract Study Objectives Obstructive sleep apnea (OSA) is associated with cardiovascular
and cerebrovascular morbidity. Patients with sickle cell disease (SCD) are at increased risk …

METHODS: We retrospectively studied pediatric (< 14 years) patients with SCD diagnosis
who were admitted with ACS or developed ACS after admission from January 2002 to …

Acute chest syndrome (ACS) is a common cause of death in sickle cell disease (SCD)
patients. Multiple studies investigated the risk factors of developing ACS; however …

This prospective observational study sought to ascertain clinical and laboratory parameters
associated with the development of acute chest syndrome (ACS) during vaso-occlusive …

Objectives: Acute chest syndrome is the leading cause of death in children with sickle cell
disease and is generally due to respiratory failure. Epidemiologic factors for a need for …

Background: Acute chest syndrome (ACS) is an acute complication of sickle cell disease
(SCD). Historically, the most common pathogens were Chlamydophila pneumoniae …

Background Acute chest syndrome (ACS) is the leading cause of death for children with
sickle cell disease (SCD). Recurrent ACS has detrimental effects on pulmonary health and …